Product correctly added to cart.

discount label
CVT 6883
View 3D

Biosynth logo

CVT 6883

CAS: 752222-83-6

Ref. 3D-FC34579

1mg
136.00 €
2mg
189.00 €
5mg
341.00 €
10mg
480.00 €
25mg
814.00 €
Estimated delivery in United States, on Tuesday 21 Jan 2025

Product Information

Name:
CVT 6883
Controlled Product
Synonyms:
  • GS 6201
  • Cvt-6883
Description:

CVT 6883 is a drug that belongs to the class of adenosine receptor antagonists. It has been shown to inhibit uptake of adenosine and decrease insulin resistance in humans. CVT 6883 also inhibits the damaged-cell response, which may be due to its ability to block the activation of adenosine receptors. This drug has been shown to have anti-inflammatory properties in animal studies and is being studied as a therapeutic for emphysema and other lung diseases. CVT 6883 also blocks an enzyme called phosphodiesterase 4B (PDE4B), which hydrolyzes cyclic AMP (cAMP). This inhibition prevents the breakdown of cAMP, leading to increased levels of this molecule. CVT 6883 has not yet been tested on humans for cancer prevention or treatment.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
446.43 g/mol
Formula:
C21H21F3N6O2
Purity:
Min. 95%
Color/Form:
Powder
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-FC34579 CVT 6883

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".